History Has An Opinion On This SNPS Price Level
A critical piece of the AI supply chain has fallen back to a price floor it has defended nine times before, forcing investors to ask if the tenth test will be the one that breaks.
Synopsys (SNPS) provides the complex software that engineers use to design the world’s most advanced microchips, placing it at the heart of the AI revolution. Yet its stock, trading around $433.82, has pulled back roughly 33% from its two-year high. It now sits in a price zone between $412.13 and $455.51 that has served as a powerful floor. Investors have stepped in to defend this level nine times. History says investors show up here. The question is, will they this time?
How Reliably Has This Level Been Defended?
The historical record is strong. Nine times since mid-2023, a slide into this price zone has been met with a significant rally. These were not minor bounces. The rebound in October 2023 led to a 37% peak gain, while another in May 2025 produced a 42% surge. Across all nine episodes, the average peak gain after the level held was 24%. This history is the reason every chart-watcher is focused on the current standoff. It’s a powerful precedent for investors returning with conviction.
| Peak Gain After Holding | Days To That Peak | |
|---|---|---|
| 6/22/2023 | 8.6% | 26 |
| 8/17/2023 | 17.0% | 56 |
| 10/26/2023 | 37% | 253 |
| 9/6/2024 | 27% | 89 |
| 4/9/2025 | 21% | 35 |
| 5/29/2025 | 42% | 62 |
| 9/11/2025 | 17.5% | 11 |
| 12/1/2025 | 22% | 42 |
| 4/15/2026 | 22% | 41 |
Is the Business Arriving Weaker This Time?
A support level holds or breaks based on the health of the business arriving at it. On the surface, Synopsys arrives with momentum. Revenue over the last twelve months grew 40%, and management just raised its full-year guidance for revenue, operating margin, and EPS. The company now expects an updated revenue range of $9.625 billion to $9.705 billion for the year. This has led some to wonder whether this is a bargain or a trap. But a closer look reveals a more complicated picture. Management acknowledged on its recent earnings call that while AI-driven demand is solid, design activity in other areas is lagging. In their words, design in the industrial and automotive sectors is “still fairly muted.”
This is the honest catch. Unlike on previous visits to this floor, the company’s growth is not as broad-based. It relies heavily on the AI semiconductor boom to offset weakness elsewhere. The Design IP segment, a critical business, saw revenue fall approximately 6% year-over-year, even as it grew 12% sequentially. While management believes the segment “bottomed in Q1,” the uneven demand across its end markets presents a risk that past investors did not have to weigh so heavily. For investors who prefer a broader software theme to a single name, other investments can offer diversified exposure.
What Decides if the New IP Model Can Hold the Line?
History is a guide, not a guarantee. The fate of this support level will likely be decided by a specific strategic shift within the company. Synopsys is actively moving its Design IP business toward what it calls “higher value” engagements, especially with hyperscalers designing custom AI silicon. This pivot away from traditional licensing toward more integrated, customized partnerships is central to its future growth. The market is no longer just watching the stock price; it’s watching for proof that this new model works.
The most important signal will be tangible business wins. Management stated they are making “very good progress” and expect to have a “few customers with signed agreements with a new business model” by the end of this fiscal year. Confirmation of these deals would validate the strategy and provide a powerful reason for investors to defend the floor again. The absence of such announcements could give sellers the upper hand. That is the one thing to watch.
If pullbacks to defensible levels are your kind of setup, our Buy the Dip screen ranks the dips where the underlying business still holds up.
One Stock At A Crossroads Should Not Decide Your Year
A stock testing its support is a stock at a decision point, and decision points cut both ways. Concentrated holders feel every one of them at full force.
The Trefis High Quality (HQ) Portfolio spreads those moments across roughly 30 quality businesses in different industries, so no single stock’s crossroads decides the outcome. It has a track record of outpacing a benchmark that combines the major three indices – the S&P 500, S&P Mid-cap, and Russell 2000. Follow the drama; diversify the stakes.